TRMT6 non-catalytic subunit is overexpressed and associated with the TNM stage in HCC, through the PI3K/AKT/mTOR axis, and it has been suggested as potential therapeutic target for this tumor type [354]. This evidence concerns the gene MTOR and neoplasm.